Pre-Open Stock Movers 09/08: (RPRX) (RAD) (JUNO) Higher; (GEVO) (NLST) (TSCO) (PIR) Lower (more...)
- Wall St. rises amid robust GDP data, mixed earnings
- ExxonMobil (XOM) Tops Q3 EPS by 5c; CapEx Light of Views
- Baker Hughes (BHI), General Electric (GE) in Partnership Talks, Not Merger Talks
- AbbVie (ABBV) Tops Q3 EPS by 1c; Boosts FY16 EPS Outlook
- Amazon.com (AMZN) Misses Q3 EPS by 26c, Offers Q4 Guidance
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Today's Pre-Open Movers
Repros Therapeutics Inc. (Nasdaq: RPRX) 31.9% HIGHER; provided posotive results of the first course of treatment from Repros ongoing study of Proellex® for the treatment of premenopausal women with confirmed symptomatic endometriosis.
Gevo, Inc. (Nasdaq: GEVO) 25.7% LOWER; announced that it intends to offer and sell, subject to market and other conditions, Series E units, with each Series E unit consisting of one share of common stock and Series I warrants to purchase a certain number of shares of common stock. The Company is also offering Series F units, in lieu of Series E units, to those purchasers whose purchase of additional Series E units in the offering would result in the purchaser beneficially owning more than 4.99% of Gevos outstanding common stock following the completion of the offering. The Series F units will consist of pre-funded warrants to purchase one share of common stock and Series I warrants to purchase a certain number of shares of common stock. The units are to be sold by Gevo subject to market and other conditions in an underwritten public offering.
Sky Solar Holdings (NASDAQ: SKYS) 20% HIGHER; reported Q2 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $17 million versus the consensus estimate of $14 million.
Tokai Pharmaceuticals Inc. (Nasdaq: TKAI) 16.5% HIGHER; announced that its Board of Directors has initiated a review of strategic alternatives for the company focused on maximizing stockholder value.
Netlist, Inc. (NASDAQ: NLST) 12.9% LOWER; announced a proposed $15 million underwritten public offering of its common stock, subject to market and other conditions. In addition, the Company intends to grant the underwriters an option to purchase additional shares equal to up to 15% of the aggregate number of shares to be sold in the offering.
Tractor Supply Company (NASDAQ: TSCO) 9.2% LOWER; provided a business update for the third quarter-to-date. Net sales for the third quarter are expected to increase approximately 4.2% to 5.0% to $1.54 billion to $1.55 billion from $1.48 billion in the third quarter of 2015, with comparable store sales ranging from flat to a decrease of (1.0)% versus an increase of 2.9% in last year's third quarter. The consensus is $1.61 billion. Given the lower sales, the Company expects net income per diluted share for the third quarter to be in the range of $0.65 to $0.67. **** versus the consensus of $0.72.
Pier 1 Imports, Inc. (NYSE: PIR) 8.3% LOWER; announced preliminary sales and earnings per share data for the second quarter ended August 27, 2016. Net sales for the second quarter decreased by approximately 6.7% compared to the same period a year ago. E-Commerce sales represented approximately 20% of net sales in the second quarter. Company comparable sales, which include e-Commerce, decreased approximately 4.3% compared to the same period a year ago. Second quarter loss per share is expected to be in the range of ($0.06) to ($0.05), excluding one-time items, if any, related to the planned departure of the Companys Chief Executive Officer, which was announced separately today. *** The Street sees Q2 revenue of $424.4 million and loss of $0.03 per share.
SUPERVALU INC. (NYSE: SVU) 7.8% LOWER; announced that it is lowering its outlook for full-year adjusted EBITDA. Although recently announced new business in its Wholesale segment is expected to begin to positively contribute to results later this fiscal year, second quarter business performance in its Retail and Save-A-Lot segments has been softer than previously anticipated. Full year adjusted EBITDA is now expected to be approximately 5.0% lower than last year.
Mitcham Industries (NASDAQ: MIND) 7.4% LOWER; reported Q2 EPS of ($0.80), $0.31 worse than the analyst estimate of ($0.49). Revenue for the quarter came in at $8.7 million versus the consensus estimate of $11.2 million.
FuelCell Energy (Nasdaq: FCEL) 7% LOWER; reported Q3 EPS of ($0.38), $0.01 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $21.7 million versus the consensus estimate of $32.28 million.
Rite Aid Corporation (NYSE:RAD) 6.8% HIGHER; Walgreens Boots Alliance, Inc. (Nasdaq: WBA) provided the following update on its pending acquisition of Rite Aid Corporation (NYSE:RAD). Walgreens Boots Alliance and Rite Aid remain actively engaged with the Federal Trade Commission (FTC) regarding its review of the pending acquisition. As a result of the progress of these discussions with the FTC staff, Walgreens Boots Alliance is exploring potential divestiture remedies to address certain issues raised in those discussions. In order to expedite that process, Walgreens Boots Alliance now expects that the most likely outcome will be that the parties will be required to divest more than the 500 stores previously communicated, but still continues to expect that fewer than 1,000 stores will be required to be divested. In addition, the company continues to believe that the acquisition will close in the second half of calendar 201
Juno Therapeutics (NASDAQ: JUNO) 6.4% HIGHER; In a paper published today in Science Translational Medicine, researchers from Fred Hutchinson Cancer Research Center shared data from an early-phase study of patients with advanced non-Hodgkin lymphoma (NHL) who received JCAR014, a Chimeric Antigen Receptor (CAR) T cell treatment, and chemotherapy. CAR T cells are made from a patients own immune cells that are then genetically engineered to better identify and kill cancer cells.
Guidewire Software (NYSE: GWRE) 5.9% LOWER; reported Q4 EPS of $0.39, $0.07 better than the analyst estimate of $0.32. Revenue for the quarter came in at $141.18 million versus the consensus estimate of $136.09 million. GUIDANCE: Guidewire Software sees Q1 2017 EPS of ($0.07)-($0.04), versus the consensus of $0.07. Guidewire Software sees Q1 2017 revenue of $84.5-88.5 million, versus the consensus of $91.71 million. Guidewire Software sees FY2017 EPS of $0.69-$0.79, versus the consensus of $0.84. Guidewire Software sees FY2017 revenue of $471.5-483.5 million, versus the consensus of $475 million.
Sage Therapeutics (NASDAQ: SAGE) 5.7% LOWER; announced that it has commenced an underwritten public offering of $150.0 million of its common stock.
Twitter (NYSE: TWTR) 5.3% LOWER; said to have 'no bids' on table, according to CNBC. The company's management is also exploring cost cuts, including layoff more workers.
DAVIDsTEA Inc. (NASDAQ: DTEA) 5.1% LOWER; reported Q2 EPS of (CDN$0.09), CDN$0.02 worse than the analyst estimate of (CDN$0.07). Revenue for the quarter came in at CDN$41.1 million versus the consensus estimate of CDN$30.93 million. comparable sales increase of 5.1% GUIDANCE: DAVIDsTEA Inc. sees Q3 2016 EPS of (CDN$0.08)-(CDN$0.09). DAVIDsTEA Inc. sees Q3 2016 revenue of CDN$43-44 million. comparable sales increase in the low-single digit range.
bluebird bio, Inc. (Nasdaq: BLUE) 5% HIGHER; announced the opening of HGB-207, a Phase 3, global, multi-center study in patients with transfusion-dependent beta-thalassemia with non-0/0 genotypes. This study will incorporate the addition of bluebird bios transduction enhancers to the hematopoietic stem cell (HSC) manufacturing process, and will be conducted under the same Investigational New Drug application (IND) as previous studies of LentiGlobin in beta-thalassemia.
Abeona Therapeutics (NASDAQ: ABEO) 4.4% HIGHER; Cantor Fitzgerald initiates coverage with a Buy rating and a price target of $21.00.
Healthcare Trust of America, Inc. (NYSE: HTA) 3.3% LOWER; announced that it has commenced an underwritten public offering of 3,500,000 shares of its common stock. In connection with the offering, HTA expects to grant the underwriters a 30-day option to purchase up to 525,000 additional shares of its common stock.
Bazaarvoice (NASDAQ: BV) 3% HIGHER; reported Q1 EPS of $0.00, $0.04 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $50.1 million versus the consensus estimate of $48.97 million.
Tesla Motors (NASDAQ: TSLA) 2% LOWER; Cowen initiated coverage on the stock with an Underperform rating and a price target of $160.
Hewlett Packard Enterprise (NYSE: HPE) 1.4% LOWER; announced plans for a spin-off and merger of its non-core software assets with Micro Focus (LSE: MCRO) in a transaction valued at approximately $8.8 billion. In addition, HPE reported Q3 EPS of $0.49, $0.04 better than the analyst estimate of $0.45. Revenue for the quarter came in at $12.2 billion versus the consensus estimate of $12.64 billion. Hewlett Packard Enterprise sees FY2016 EPS of $1.90-$1.95, versus the consensus of $1.87.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pre-Open Stock Movers 10/27: (PRQR) (OCN) (TWTR) Higher; (CYH) (GNC) (RNWK) Lower (more...)
- Tesla (TSLA) Posts Q3 adj.-EPS of 71c
- Abbott (ABT) Shares Active Amid St. Jude (STJ) Headlines
Create E-mail Alert Related CategoriesSpecial Dividends
Related EntitiesCantor Fitzgerald, Twitter, Cowen & Co, Layoffs, Tesla, Earnings, Pre-Open Losers, Pre-Open Winners, Definitive Agreement, Pre Market Movers
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!